Your shopping cart is currently empty

FMJ-01-042 is a low-efficacy partial agonist capable of crossing the blood-brain barrier, exhibiting high affinity (Kᵢ=4.33 nM) and strong subtype selectivity for the dopamine D4 receptor. It demonstrates good metabolic stability and is suitable for research into neuropsychiatric disorders.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | FMJ-01-042 is a low-efficacy partial agonist capable of crossing the blood-brain barrier, exhibiting high affinity (Kᵢ=4.33 nM) and strong subtype selectivity for the dopamine D4 receptor. It demonstrates good metabolic stability and is suitable for research into neuropsychiatric disorders. |
| In vitro | FMJ-01-042 (Compound 18) functions as a D4R-mediated β-arrestin recruitment antagonist. It exhibits commendable metabolic stability in rat liver microsomes, with a half-life (t 1/2) of 56.77 minutes. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.